Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Fremanezumab by Teva Pharmaceutical Industries for Rosacea: Likelihood of Approval
Fremanezumab is under clinical development by Teva Pharmaceutical Industries and currently in Phase I for Rosacea. According to GlobalData, Phase...